Todd Rosengarten is the leader of the non-small molecule CMC development, technical operations, engineering and manufacturing practice and co-leads the tools, technology and services practice at Klein Hersh. He joined KH in 2008 and has driven the growth of the practice, working closely with venture, private equity, large biopharma companies and a variety of small biotechs developing novel therapies, tools and technologies.
As the leader of the non-small molecule CMC development, technical operations, engineering and manufacturing practice, Todd’s responsibilities include:
- Partnering with large biopharma companies, small biotech, and contract development & manufacturing organizations (CDMOs) on the recruitment of senior operational and technical leadership executives to lead products out of discovery and into the clinic, helping to ensure clinical supply, eventual commercial launch, and on-going commercial support.
Klein Hersh’s tools, technology, and services practice is focused on helping those businesses find broad organizational leadership, including CEO, CCO, COO, CTO, and CBO roles. His responsibilities also include Board of Directors and SAB construction.
Each year, Todd is an attendee and participant at JPM, ASGCT, Meeting on the Mesa, BIO, DCAT and the Phacilitate Cell and Gene Therapy conferences.
